The BriefBrief · Intelligence, not news.
Download on the App Store Get it on Google Play

WHO Says Two Bundibugyo Vaccines Will Enter DRC Trials

WHO chief Tedros Adhanom Ghebreyesus said two candidate vaccines developed specifically for the Bundibugyo Ebola strain are expected to begin testing in the Democratic Republic of Congo as early as next week. The Tumaini trial will assess their safety, efficacy and ability to trigger an immune response, using ring vaccination for high-risk contacts.

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.
Lee hopes North Korea dialogue can bring lasting peace
Lee Jae Myung Nov 19, 2026 at 12:04 AM ET
Western powers press Iran to resume nuclear inspections
United States Nov 19, 2026 at 12:04 AM ET
O’Neil Says Trump-Xi-Putin Talks’ Agenda Is Unclear
Shannon O’neil Nov 19, 2026 at 12:03 AM ET
Trump urges Americans to relax over tech outages
Donald Trump Nov 19, 2026 at 12:03 AM ET

Page 92 of 22954

Same format. Every time.

Continue reading — sign in or create a free account with